Ajay Verma
Chief Executive Officer presso Sahayata Microfinance Pvt Ltd.
Posizioni attive di Ajay Verma
Società | Posizione | Inizio | Fine |
---|---|---|---|
Sahayata Microfinance Pvt Ltd.
Sahayata Microfinance Pvt Ltd. Finance/Rental/LeasingFinance Sahayata Microfinance Pvt Ltd. engages in arranging loans. The company was founded in September 2006 and is headquartered in Udaipur, India. | Chief Executive Officer | 25/02/2010 | - |
Storia della carriera di Ajay Verma
Precedenti posizioni note di Ajay Verma
Società | Posizione | Inizio | Fine |
---|---|---|---|
YUMANITY THERAPEUTICS | Chief Tech/Sci/R&D Officer | 13/04/2021 | 01/01/2022 |
CODIAK BIOSCIENCES | Corporate Officer/Principal | - | 05/03/2021 |
Formazione di Ajay Verma
The Johns Hopkins University | Doctorate Degree |
University of Rajasthan | Undergraduate Degree |
Jai Narain Vyas University | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
India | 4 |
Posizioni
Chief Executive Officer | 1 |
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Settori
Consumer Services | 4 |
Health Technology | 3 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 3 |
---|---|
Sahayata Microfinance Pvt Ltd.
Sahayata Microfinance Pvt Ltd. Finance/Rental/LeasingFinance Sahayata Microfinance Pvt Ltd. engages in arranging loans. The company was founded in September 2006 and is headquartered in Udaipur, India. | Finance |
Codiak BioSciences, Inc.
Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Codiak BioSciences, Inc. engages in the development and manufacturing of exosomes. It engages in harnessing exosomes, therapeutic applications, diagnostic applications, and proprietary production. The firm develops engEx Platform, a proprietary and versatile exosome engineering and manufacturing platform, to expand upon the innate properties of exosomes to design novel exosome therapeutics. Codiak BioSciences was founded by Douglas E. William, Raghu Kalluri, and Eric S. Lander in 2015 and is headquartered in Cambridge, MA. | Health Technology |
Yumanity Therapeutics, Inc.
Yumanity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Yumanity Therapeutics, Inc. is a clinical stage biopharmaceuticals company. It is accelerating the revolution in the treatment of neurodegenerative diseases through its transformative scientific foundation and drug discovery platform. Its platform is based on technology, which enables the rapid screening for novel disease targets and disease modifying drugs that can overcome toxicity in disease-causing gene networks, which usually results from an aberrant accumulation of misfolded proteins in the brain. The company was founded by Susan Lindquist and Tony Coles in December 2014 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Ajay Verma
- Esperienza